search
Back to results

Liverpool Care Pathway for the Dying at Residential Care Homes

Primary Purpose

End-of-life Care

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Liverpool care pathway
Sponsored by
Umeå University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for End-of-life Care focused on measuring palliative care, nursing homes, Liverpool care pathway

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • nursing homes in Skellefteå municipality, Sweden

Exclusion Criteria:

-

Sites / Locations

  • Skellefteå municipality

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

No Intervention

Arm Label

Liverpool care pathway

control

Arm Description

Liverpool care pathway for dying at nursing homes

Usual care is performed for the control group

Outcomes

Primary Outcome Measures

quality of care
changes between the groups about values of symptom scores on the Edmonton assessment scale (ESAS) and the views of informal carers-evaluation of services (VOICES)assessed by close relative

Secondary Outcome Measures

place of death
changes between the groups
drug consumption

Full Information

First Posted
August 23, 2011
Last Updated
June 13, 2013
Sponsor
Umeå University
search

1. Study Identification

Unique Protocol Identification Number
NCT01428206
Brief Title
Liverpool Care Pathway for the Dying at Residential Care Homes
Official Title
Liverpool Care Pathway for the Dying at Residential Care Homes
Study Type
Interventional

2. Study Status

Record Verification Date
June 2013
Overall Recruitment Status
Completed
Study Start Date
June 2009 (undefined)
Primary Completion Date
December 2012 (Actual)
Study Completion Date
December 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Umeå University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Liverpool Care Pathway for the dying patient (LCP) was developed to transfer the care practice from the hospice setting to the hospital setting in UK. LCP is a pathway with standardized registration method to monitor the care and its results. The primary aim is to study the effects of LCP on dying patients symptom burden and communication with close relatives and health care professionals.
Detailed Description
All residential care homes in Skellefteå municipality are included in the study and randomized either to control or intervention group. During the baseline period the care is provided as usual. During the intervention period the LCP is used for patients for whom the dying phase is diagnosed in the intervention group. Usual care is performed for the control group. After death of a patient a close relative fill in a questionnaire.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
End-of-life Care
Keywords
palliative care, nursing homes, Liverpool care pathway

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
260 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Liverpool care pathway
Arm Type
Other
Arm Description
Liverpool care pathway for dying at nursing homes
Arm Title
control
Arm Type
No Intervention
Arm Description
Usual care is performed for the control group
Intervention Type
Other
Intervention Name(s)
Liverpool care pathway
Other Intervention Name(s)
end-of-life care, palliative care
Intervention Description
Liverpool care pathway is started tha last day in life for elderly at nursing homes
Primary Outcome Measure Information:
Title
quality of care
Description
changes between the groups about values of symptom scores on the Edmonton assessment scale (ESAS) and the views of informal carers-evaluation of services (VOICES)assessed by close relative
Time Frame
one month to six months after the relatives death
Secondary Outcome Measure Information:
Title
place of death
Description
changes between the groups
Time Frame
the time of death
Title
drug consumption
Time Frame
the last three days before death

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: nursing homes in Skellefteå municipality, Sweden Exclusion Criteria: -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Margareta Brännström, PhD
Organizational Affiliation
Department of nursing, Umeå University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Skellefteå municipality
City
Skellefteå
State/Province
Västerbotten
Country
Sweden

12. IPD Sharing Statement

Learn more about this trial

Liverpool Care Pathway for the Dying at Residential Care Homes

We'll reach out to this number within 24 hrs